Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Advanced Parenting Education in Pediatrics: The APEP Project
Verified date | February 2013 |
Source | Tufts Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
This study will evaluate the effectiveness of a parent training program in improving parenting skills and reducing behavioral symptoms in young children who are at risk for developing childhood behavior disorders.
Status | Completed |
Enrollment | 345 |
Est. completion date | December 2011 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 22 Months to 38 Months |
Eligibility |
Inclusion Criteria: Parent or primary caregiver of a child who fits the following criteria: - Receives a positive result on behavioral screening Exclusion Criteria: Parent or primary caregiver of a child who fits the following criteria: - Diagnosis of pervasive developmental disorder or global developmental delay |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | MGH Chelsea Healthcare Center | Chelsea | Massachusetts |
United States | Codman Square Health Center | Dorchester | Massachusetts |
United States | Martha Eliot Health Center | Jamaica Plain | Massachusetts |
United States | Medical Associates Pediatrics | Leominster | Massachusetts |
United States | Southboro Medical Group | Southboro | Massachusetts |
United States | Pediatrics West | Westford | Massachusetts |
United States | Westwood-Mansfield Pediatric Associates | Westwood | Massachusetts |
United States | Wilmington Pediatrics | Wilmington | Massachusetts |
United States | Woburn Pediatric Associates | Woburn | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Tufts Medical Center | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Parenting behavior | Measured post-intervention and at 6- and 12-month follow-ups | No | |
Primary | Child disruptive behaviors | Measured post-intervention and at 6- and 12-month follow-ups | No | |
Secondary | Child and parent functional status/impairment | Measured post-intervention and at 6- and 12-month follow-ups | No | |
Secondary | Parenting stress | Measured post-intervention and at 6- and 12-month follow-ups | No | |
Secondary | Family functioning | Measured post-intervention and at 6- and 12-month follow-ups | No | |
Secondary | Consumer perspectives | Measured post-intervention and at 6- and 12-month follow-ups | No | |
Secondary | Cost of services | Measured post-intervention and at 6- and 12-month follow-ups | No | |
Secondary | Barriers to treatment | Measured post-intervention and at 6- and 12-month follow-ups | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |